Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 121 AL 135

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?

D'Amelio M, Di Lazzaro V.

Brain. 2023 Jun 1;146(6):e43-e45. doi: 10.1093/brain/awad019.

Reply: Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?

Koch G, Martorana A.

Brain. 2023 Jun 1;146(6):e46-e47. doi: 10.1093/brain/awad020.

Clinical efficacy and safety of compound Congrong Yizhi Capsules on Alzheimer's disease in mainland China: A systematic review with trial sequential analysis and GRADE assessment

Wang Y, Wang N, Xu Z, Liu S, Liang X, Zhang Y, Jin X.

J Ethnopharmacol. 2023 Jun 12;309:116208. doi: 10.1016/j.jep.2023.116208. Epub 2023 Jan 31.

APOE4: A Culprit for the Vulnerability of COVID-19 in Alzheimer's Patients

Goyal A, Kushwah PS, Agrawal N, Pathak S.

Curr Neurovasc Res. 2023;20(1):162-169. doi: 10.2174/1567202620666230202140612.

The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis

Wu L, Xian X, Tan Z, Dong F, Xu G, Zhang M, Zhang F.

Mol Neurobiol. 2023 May;60(5):2832-2850. doi: 10.1007/s12035-023-03245-7. Epub 2023 Feb 3.

Adult hippocampal neurogenesis in Alzheimer's disease: A roadmap to clinical relevance

Salta E, Lazarov O, Fitzsimons CP, Tanzi R, Lucassen PJ, Choi SH.

Cell Stem Cell. 2023 Feb 2;30(2):120-136. doi: 10.1016/j.stem.2023.01.002.

An insight into the TAM system in Alzheimer's disease

Zhou S, Li Y, Zhang Z, Yuan Y.

Int Immunopharmacol. 2023 Mar;116:109791. doi: 10.1016/j.intimp.2023.109791. Epub 2023 Feb 2.

Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease

Sharma A, Piplani P.

Curr Top Med Chem. 2023;23(13):1260-1276. doi: 10.2174/1568026623666230203141543.

Roles of Microglia in AD Pathology

Rong G, Hongrong W, Qingqi L, Jianfeng Z.

Curr Alzheimer Res. 2023;19(13):854-869. doi: 10.2174/1567205020666230203112351.

Treatment of Alzheimer's Disease: Contemporary Perspectives in Medicinal Chemistry

de Oliveira AS.

Curr Med Chem. 2023;30(6):667-668. doi: 10.2174/092986733006221208094952.

Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease

Vitek GE, Decourt B, Sabbagh MN.

Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28.

Myeloid Cells As a Promising Target for Brain-Bone Degenerative Diseases from a Metabolic Point of View

Pang Y, Zhu S, Xu J, Su C, Wu B, Zhang C, Gao J.

Adv Biol (Weinh). 2023 Oct;7(10):e2200321. doi: 10.1002/adbi.202200321. Epub 2023 Feb 7.

Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease

Mahley RW.

Curr Opin Neurobiol. 2023 Apr;79:102684. doi: 10.1016/j.conb.2023.102684. Epub 2023 Feb 6.

Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota

Salminen A.

J Mol Med (Berl). 2023 Mar;101(3):201-222. doi: 10.1007/s00109-023-02289-5. Epub 2023 Feb 9.

Local and Systemic Hypoxia as Inductors of Increased Aluminum and Iron Brain Accumulation Promoting the Onset of Alzheimer's Disease

Cirovic A, Cirovic A, Orisakwe OE, Lima RR.

Biol Trace Elem Res. 2023 Nov;201(11):5134-5142. doi: 10.1007/s12011-023-03599-y. Epub 2023 Feb 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias